ATOVAQUONE ORAL SUSPENSION

6939 reported adverse events

Drug classes: Antimalarial [EPC] Antiprotozoal [EPC]

These side effects are most commonly reported by patients taking ATOVAQUONE ORAL SUSPENSION:

# Side effect Count
0 OFF LABEL USE 742
1 DRUG INEFFECTIVE 392
2 PYREXIA 367
3 DIARRHOEA 355
4 PNEUMONIA 326
5 NAUSEA 313
6 CONDITION AGGRAVATED 261
7 ACUTE KIDNEY INJURY 256
8 NEUTROPENIA 250
9 DEATH 241
See all common reactions for ATOVAQUONE ORAL SUSPENSION

ATOVAQUONE ORAL SUSPENSION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IVTH NERVE PARALYSIS 42 0.1772
1 CUTANEOUS MUCORMYCOSIS 21 0.1141
2 ACANTHAMOEBA INFECTION 17 0.0904
3 MALACOPLAKIA 28 0.0611
4 PULMONARY NOCARDIOSIS 46 0.0558
5 NOCARDIOSIS 92 0.0359
6 IGA NEPHROPATHY 45 0.0271
7 PNEUMOCYSTIS JIROVECII INFECTION 25 0.0209
8 ENTEROCOCCAL BACTERAEMIA 20 0.0189
9 CEREBRAL TOXOPLASMOSIS 16 0.0171
See all enriched reactions for ATOVAQUONE ORAL SUSPENSION